Dr Reddy#39;s Labs share price gains over launch of COVID-19 treatment drug
Dr Reddys Laboratories share price added a percent in the morning session on June 28 after the company launched 2-deoxy-D-glucose (2-DG), a therapeutic application for treatment of COVID-19 patients.
The stock was trading at Rs 5,352.10, up Rs 40.75, or…
